This site is intended for Healthcare Professionals only.

Pharmacy bodies demand continued pharmacy access to Summary Care Records

Date:

Share post:

The Royal Pharmaceutical Society and the Pharmaceutical Standards Negotiating Committee have demanded that pharmacists should be given continued access to the additional information in Summary Care Records (SCRs) beyond the Covid-19 pandemic.

In a letter to NHS officials, RPS and PSNC noted that community pharmacists need comprehensive access to electronic health records to provide the person-centred services set out in the NHS Long Term Plan.

Currently under the Coronavirus Bill, pharmacists and their teams have been able to access data from patients SCRs and medicines-related information, specifically relating to Covid-19.

The letter, signed jointly by Simon Dukes, PSNC chief executive, and Claire Anderson, chair of the English Pharmacy Board, calls for new legislation to be introduced to enable ongoing pharmacy access to SCRs.

“People are becoming increasingly familiar to working digitally and there is growing opinion on sharing information to provide the best possible care for patients,” Anderson said.

“We support the ongoing work to set common clinical standards, which allows crucial information to flow across the health system. Ensuring that community pharmacy is part of that system is critical in providing better patient care.”

The letter also highlights that local health and care record (LHCR) access should be standard for pharmacy professionals to better support pharmacy patient care.

The development of IT LHCR compatibility standards are also needed so pharmacists can access whichever LHCRs using their clinical system, it adds.

Alistair Buxton, PSNC director of NHS Services, said: “We need the NHS to do more to help us help patients. Pharmacy professionals should be able to easily access relevant patient information so they can support patients to make the most of their medicines and identify any possible concerns, thereby reducing the likelihood of problems escalating.

“Access to this additional information during the pandemic has been crucial for pharmacy teams, and it would be a retrograde step if the amount of detail available to them reverts to its pre-pandemic level.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

DHSC Plans to Allow Hub and Spoke Models Across Different Pharmacy Ownerships Soon

It has decided to proceed with the implementation of the two hub and spoke models that it consulted...

NHS Long Term Workforce Plan: 350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places The government has...

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well...

Cipla, Glenmark recall products from US market due to manufacturing issues

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution   Two Indian pharmaceutical companies,...